To find out more about Pharmaceutical Product Development, please contact:

Robert Feltz, Director of Analytical and Formulation Services

Our formulation development services capabilities:

  • Immediate, orally disintegrating, modified, delayed, extended release and controlled-release tablets and capsules
  • Over-encapsulation for double-blind studies
  • Bioavailability enhancement
  • Highly-potent compounds
  • DEA controlled substances (Schedule I-V)
  • Combination of multiple APIs
  • Matching placebo (solid, semi-solid and liquid dosage form)
  • Powder/blend filling in bottles, vials and pouches using automatic filling machine
  • Drug layering and particle coating (Wurster column and top spray coating processes)
  • Liquid in hard gel capsule and banding/sealing
  • Solution, suspension, powder for reconstitution
  • Tablet, capsule and pellet coating
  • Semi-solid and topical formulation development

Trust Sharp with your formulation development

Our formulation development services and analytical testing capabilities can prepare your innovations for Phase I in as little as four weeks. We know what it takes to get your product into clinical trials, evaluating critical quality attributes (CQAs) from R&D to GMP manufacturing.

We treat your formulation as our own, working closely with you to overcome challenges and optimize your product for a wide range of dosage forms. Our time-tested approach has flexibility built in, backed up by our robust quality-by-design framework, to maximize efficiency and minimize risk.

With Sharp, you get a partnership shaped around you. We are committed to protecting your innovation and supporting you to the next stop on your journey, clinical trials.

Our analytical and research & development teams use advanced investigative technologies to provide clients with the innovation required to move a product from clinical development to commercialization and ultimately to patients.